详情页

当前位置：首页 > 详情页

Cardiac tamponade, a rare complication of gastric cardia cancer resection after neoadjuvant chemotherapy combined with immunotherapy: a case report and literature review (vol 13, 1189500, 2023)

6| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Hebei Med Univ, Hosp 4, Dept Anesthesiol, Shijiazhuang, Hebei, Peoples R China [2]Hebei Med Univ, Hosp 4, Dept Thorac Surg, Shijiazhuang, Hebei, Peoples R China

出处：

DOI：

ISSN：

关键词： cardiac tamponade gastric cardia cancer immunotherapy neoadjuvant chemotherapy transthoracic gastric resection

摘要：

语种：

WOS：

PubmedID：

中科院分区：

出版当年[2025]版：

大类 | 3 区医学

小类 | 4 区肿瘤学

最新[2025]版：

大类 | 3 区医学

小类 | 4 区肿瘤学

JCR分区：

出版当年[2024]版：

Q2 ONCOLOGY

最新[2024]版：

Q2 ONCOLOGY

影响因子： 3.3 最新[2024版] 3.8 最新五年平均 3.3 出版当年[2024版] 3.8 出版当年五年平均 3.5 出版前一年[2023版]

第一作者：

第一作者机构： [1]Hebei Med Univ, Hosp 4, Dept Anesthesiol, Shijiazhuang, Hebei, Peoples R China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Cardiac tamponade, a rare complication of gastric cardia cancer resection after neoadjuvant chemotherapy combined with immunotherapy: a case report and literature review [2]Corrigendum: Cardiac tamponade, a rare complication of gastric cardia cancer resection after neoadjuvant chemotherapy combined with immunotherapy: a case report and literature review [3]Tumor Immune Microenvironment Remodeling and Prognosis of Patients with Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy with and without Immunotherapy [4]A positive family history of esophageal/gastric cardia cancer with gastric cardia adenocarcinoma is associated with a younger age at onset and more likely with another synchronous esophageal/gastric cardia cancer in a Chinese high-risk area [5]Surgical treatment for cancer of the oesophagus and gastric cardia in Hebei, China [6]Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis [7]Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching [8]To Explore the Efficacy of Hypofractionated Radiotherapy Followed by AG Regimen Chemotherapy Plus Camrelizumab Immunotherapy as Neoadjuvant Therapy for Locally Advanced Pancreatic Cancer [9]Tumor immune microenvironment remodeling and prognosis of patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy with and without immunotherapy: a retrospective cohort study [10]Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China